Transforming growth factor-β1 incorporation in an α-tricalcium phosphate/dicalcium phosphate dihydrate/tetracalcium phosphate monoxide cement: release characteristics and physicochemical properties
- 26 November 2001
- journal article
- Published by Elsevier in Biomaterials
- Vol. 23 (4) , 1261-1268
- https://doi.org/10.1016/s0142-9612(01)00246-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary resultsEuropean Spine Journal, 1999
- ??-BSM??: A Biomimetic Bone Substitute and Drug Delivery VehicleClinical Orthopaedics and Related Research, 1999
- Polypeptide growth factors: targeted delivery systemsBiomaterials, 1997
- Gentamicin-Loaded Hydraulic Calcium Phosphate Bone Cement as Antibiotic Delivery SystemJournal of Pharmaceutical Sciences, 1997
- Repair of Five Distal Radius Fractures with an Investigational Cancellous Bone Cement: A Preliminary ReportJournal of Orthopaedic Trauma, 1997
- Transforming growth factor‐β1 enhances bone healing to unloaded tricalcium phosphate coated implants: An experimental study in dogsJournal of Orthopaedic Research, 1996
- Skeletal Repair by in Situ Formation of the Mineral Phase of BoneScience, 1995
- A Novel Skeletal Drug-Delivery System Using Self-Setting Calcium Phosphate Cement. 3. Physicochemical Properties and Drug-Release Rate of Bovine Insulin and Bovine AlbuminJournal of Pharmaceutical Sciences, 1994
- Self‐Setting Hydroxyapatite Cement: A Novel Skeletal Drug‐Delivery System for AntibioticsJournal of Pharmaceutical Sciences, 1992
- Rapid publication TGF-β1 induces bone closure of skull defectsJournal of Bone and Mineral Research, 1991